25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

MLSS (Milestone Scientific) Stock Analysis
Buy, Hold or Sell?

Let's analyze Milestone Scientific together

I guess you are interested in Milestone Scientific. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Milestone Scientific’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Milestone Scientific’s Price Targets

I'm going to help you getting a better view of Milestone Scientific. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Milestone Scientific

I send you an email if I find something interesting about Milestone Scientific.

1. Quick Overview

1.1. Quick analysis of Milestone Scientific (30 sec.)










1.2. What can you expect buying and holding a share of Milestone Scientific? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.07
Expected worth in 1 year
$0.05
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-0.02
Return On Investment
-2.2%

For what price can you sell your share?

Current Price per Share
$0.95
Expected price per share
$0.82 - $1.12
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Milestone Scientific (5 min.)




Live pricePrice per Share (EOD)
$0.95
Intrinsic Value Per Share
$-0.78 - $-0.38
Total Value Per Share
$-0.71 - $-0.31

2.2. Growth of Milestone Scientific (5 min.)




Is Milestone Scientific growing?

Current yearPrevious yearGrowGrow %
How rich?$5.8m$7.5m-$831.7k-12.4%

How much money is Milestone Scientific making?

Current yearPrevious yearGrowGrow %
Making money-$1.3m-$1.7m$438.3k33.0%
Net Profit Margin-62.1%-74.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Milestone Scientific (5 min.)




2.4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#139 / 163

Most Revenue
#137 / 163

Most Profit
#106 / 163

Most Efficient
#137 / 163
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Milestone Scientific?

Welcome investor! Milestone Scientific's management wants to use your money to grow the business. In return you get a share of Milestone Scientific.

First you should know what it really means to hold a share of Milestone Scientific. And how you can make/lose money.

Speculation

The Price per Share of Milestone Scientific is $0.95. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Milestone Scientific.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Milestone Scientific, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.07. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Milestone Scientific.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.03-2.7%-0.02-1.8%-0.02-2.4%-0.02-2.3%-0.02-2.4%-0.02-2.3%
Usd Book Value Change Per Share0.00-0.1%-0.01-0.5%-0.01-0.6%-0.01-1.0%0.000.4%0.00-0.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-0.1%-0.01-0.5%-0.01-0.6%-0.01-1.0%0.000.4%0.00-0.3%
Usd Price Per Share0.93-0.87-0.78-0.81-1.33-1.38-
Price to Earnings Ratio-9.14-7.56--8.90--3.10--13.27--15.42-
Price-to-Total Gains Ratio-708.40--188.12--41.15--93.20-3.83--286.51-
Price to Book Ratio12.76-10.65-8.14-8.15-8.84-18.05-
Price-to-Total Gains Ratio-708.40--188.12--41.15--93.20-3.83--286.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.95
Number of shares1052
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (1052 shares)-5.383.52
Gains per Year (1052 shares)-21.5314.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-22-320144
20-43-5402818
30-65-7604232
40-86-9805646
50-108-12007060
60-129-14208474
70-151-16409888
80-172-1860113102
90-194-2080127116
100-215-2300141130

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.019.00.05.0%2.038.00.05.0%13.0102.00.011.3%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%6.014.00.030.0%12.028.00.030.0%41.074.00.035.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.0115.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%6.014.00.030.0%12.028.00.030.0%41.074.00.035.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Milestone Scientific compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.005+289%-0.006+365%-0.010+630%0.003-139%-0.003+120%
Book Value Per Share--0.0730.084-13%0.096-24%0.106-31%0.148-51%0.112-35%
Current Ratio--2.4802.703-8%3.225-23%3.383-27%4.430-44%3.435-28%
Debt To Asset Ratio--0.4050.375+8%0.322+26%0.317+28%0.266+52%0.403+0%
Debt To Equity Ratio--0.6800.604+13%0.468+45%0.469+45%0.374+82%1.215-44%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--73706947.92968740302.310+7%62765909.278+17%65784000.679+12%110324822.658-33%110143311.448-33%
Eps---0.026-0.017-34%-0.022-12%-0.022-14%-0.022-12%-0.022-15%
Ev To Ebitda Ratio---9.175-9.944+8%-9.103-1%-9.224+1%-17.467+90%160.456-106%
Ev To Sales Ratio--9.1528.231+11%6.712+36%7.605+20%23.683-61%17.857-49%
Free Cash Flow Per Share---0.019-0.010-46%-0.014-24%-0.015-20%-0.016-13%-0.011-40%
Free Cash Flow To Equity Per Share---0.019-0.010-46%-0.005-71%-0.012-36%0.001-3025%0.001-2512%
Gross Profit Margin--1.0001.0000%1.857-46%1.375-27%1.226-18%1.113-10%
Intrinsic Value_10Y_max---0.380----------
Intrinsic Value_10Y_min---0.783----------
Intrinsic Value_1Y_max---0.045----------
Intrinsic Value_1Y_min---0.064----------
Intrinsic Value_3Y_max---0.129----------
Intrinsic Value_3Y_min---0.206----------
Intrinsic Value_5Y_max---0.207----------
Intrinsic Value_5Y_min---0.362----------
Market Cap74460620.000+0%74413261.92969277247.310+7%61022469.278+22%63586593.513+17%104500287.508-29%108586656.948-31%
Net Profit Margin---1.011-0.621-39%-0.743-27%-0.786-22%-1.675+66%-1.230+22%
Operating Margin---1.014-0.640-37%-0.762-25%-0.808-20%-1.708+68%-1.194+18%
Operating Ratio--2.0141.955+3%1.760+14%1.911+5%2.765-27%2.198-8%
Pb Ratio12.996+2%12.75810.653+20%8.145+57%8.148+57%8.839+44%18.052-29%
Pe Ratio-9.310-2%-9.1397.561-221%-8.896-3%-3.100-66%-13.270+45%-15.423+69%
Price Per Share0.950+2%0.9330.872+7%0.776+20%0.806+16%1.330-30%1.384-33%
Price To Free Cash Flow Ratio-12.508-2%-12.279-6.483-47%-13.699+12%-9.955-19%-23.606+92%-24.747+102%
Price To Total Gains Ratio-721.612-2%-708.395-188.121-73%-41.155-94%-93.198-87%3.827-18613%-286.506-60%
Quick Ratio--0.9971.036-4%2.473-60%3.022-67%4.882-80%3.135-68%
Return On Assets---0.208-0.132-37%-0.159-24%-0.142-31%-0.121-42%-0.144-31%
Return On Equity---0.349-0.218-38%-0.229-34%-0.209-40%-0.169-52%-0.411+18%
Total Gains Per Share---0.001-0.005+289%-0.006+365%-0.010+630%0.003-139%-0.003+120%
Usd Book Value--5832700.0006710190.250-13%7541902.250-23%8343601.583-30%11632897.900-50%8769740.375-33%
Usd Book Value Change Per Share---0.001-0.005+289%-0.006+365%-0.010+630%0.003-139%-0.003+120%
Usd Book Value Per Share--0.0730.084-13%0.096-24%0.106-31%0.148-51%0.112-35%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--73706947.92968740302.310+7%62765909.278+17%65784000.679+12%110324822.658-33%110143311.448-33%
Usd Eps---0.026-0.017-34%-0.022-12%-0.022-14%-0.022-12%-0.022-15%
Usd Free Cash Flow---1515016.000-805072.750-47%-1136089.500-25%-1191870.333-21%-1293493.550-15%-895186.050-41%
Usd Free Cash Flow Per Share---0.019-0.010-46%-0.014-24%-0.015-20%-0.016-13%-0.011-40%
Usd Free Cash Flow To Equity Per Share---0.019-0.010-46%-0.005-71%-0.012-36%0.001-3025%0.001-2512%
Usd Market Cap74460620.000+0%74413261.92969277247.310+7%61022469.278+22%63586593.513+17%104500287.508-29%108586656.948-31%
Usd Price Per Share0.950+2%0.9330.872+7%0.776+20%0.806+16%1.330-30%1.384-33%
Usd Profit---2035535.000-1327150.750-35%-1765491.750-13%-1700050.167-16%-1743122.100-14%-1685661.500-17%
Usd Revenue--2013514.0002098649.250-4%2369672.750-15%2214657.500-9%2160367.650-7%2291363.150-12%
Usd Total Gains Per Share---0.001-0.005+289%-0.006+365%-0.010+630%0.003-139%-0.003+120%
 EOD+5 -3MRQTTM+13 -24YOY+11 -273Y+13 -255Y+5 -3310Y+11 -27

3.3 Fundamental Score

Let's check the fundamental score of Milestone Scientific based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-9.310
Price to Book Ratio (EOD)Between0-112.996
Net Profit Margin (MRQ)Greater than0-1.011
Operating Margin (MRQ)Greater than0-1.014
Quick Ratio (MRQ)Greater than10.997
Current Ratio (MRQ)Greater than12.480
Debt to Asset Ratio (MRQ)Less than10.405
Debt to Equity Ratio (MRQ)Less than10.680
Return on Equity (MRQ)Greater than0.15-0.349
Return on Assets (MRQ)Greater than0.05-0.208
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Milestone Scientific based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.780
Ma 20Greater thanMa 500.953
Ma 50Greater thanMa 1000.963
Ma 100Greater thanMa 2001.026
OpenGreater thanClose0.980
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Milestone Scientific

Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for all dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. In addition, the company provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, it offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

Fundamental data was last updated by Penke on 2025-04-24 12:48:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Milestone Scientific earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Milestone Scientific to theΒ Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -101.1%Β means thatΒ $-1.01 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Milestone Scientific:

  • The MRQ is -101.1%. The company is making a huge loss. -2
  • The TTM is -62.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-101.1%TTM-62.1%-39.0%
TTM-62.1%YOY-74.3%+12.2%
TTM-62.1%5Y-167.5%+105.4%
5Y-167.5%10Y-123.0%-44.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-101.1%5.5%-106.6%
TTM-62.1%4.6%-66.7%
YOY-74.3%6.8%-81.1%
3Y-78.6%7.2%-85.8%
5Y-167.5%6.9%-174.4%
10Y-123.0%7.2%-130.2%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Milestone Scientific is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Milestone Scientific to theΒ Medical Instruments & Supplies industry mean.
  • -20.8% Return on Assets means thatΒ Milestone Scientific generatedΒ $-0.21 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Milestone Scientific:

  • The MRQ is -20.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -13.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-20.8%TTM-13.2%-7.6%
TTM-13.2%YOY-15.9%+2.7%
TTM-13.2%5Y-12.1%-1.1%
5Y-12.1%10Y-14.4%+2.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.8%1.0%-21.8%
TTM-13.2%0.8%-14.0%
YOY-15.9%1.3%-17.2%
3Y-14.2%1.3%-15.5%
5Y-12.1%1.5%-13.6%
10Y-14.4%1.7%-16.1%
4.3.1.3. Return on Equity

Shows how efficient Milestone Scientific is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Milestone Scientific to theΒ Medical Instruments & Supplies industry mean.
  • -34.9% Return on Equity means Milestone Scientific generated $-0.35Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Milestone Scientific:

  • The MRQ is -34.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -21.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-34.9%TTM-21.8%-13.1%
TTM-21.8%YOY-22.9%+1.1%
TTM-21.8%5Y-16.9%-4.9%
5Y-16.9%10Y-41.1%+24.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-34.9%2.7%-37.6%
TTM-21.8%1.8%-23.6%
YOY-22.9%2.7%-25.6%
3Y-20.9%2.9%-23.8%
5Y-16.9%3.4%-20.3%
10Y-41.1%3.2%-44.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Milestone Scientific.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Milestone Scientific is operatingΒ .

  • Measures how much profit Milestone Scientific makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Milestone Scientific to theΒ Medical Instruments & Supplies industry mean.
  • An Operating Margin of -101.4%Β means the company generated $-1.01 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Milestone Scientific:

  • The MRQ is -101.4%. The company is operating very inefficient. -2
  • The TTM is -64.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-101.4%TTM-64.0%-37.4%
TTM-64.0%YOY-76.2%+12.3%
TTM-64.0%5Y-170.8%+106.8%
5Y-170.8%10Y-119.4%-51.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-101.4%7.9%-109.3%
TTM-64.0%6.8%-70.8%
YOY-76.2%7.6%-83.8%
3Y-80.8%7.8%-88.6%
5Y-170.8%9.0%-179.8%
10Y-119.4%10.1%-129.5%
4.3.2.2. Operating Ratio

Measures how efficient Milestone Scientific is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 2.01 means that the operating costs are $2.01 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Milestone Scientific:

  • The MRQ is 2.014. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.955. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.014TTM1.955+0.060
TTM1.955YOY1.760+0.194
TTM1.9555Y2.765-0.810
5Y2.76510Y2.198+0.566
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0141.128+0.886
TTM1.9551.104+0.851
YOY1.7601.021+0.739
3Y1.9111.055+0.856
5Y2.7651.056+1.709
10Y2.1980.998+1.200
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Milestone Scientific.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Milestone Scientific is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Medical Instruments & Supplies industry mean).
  • A Current Ratio of 2.48Β means the company has $2.48 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Milestone Scientific:

  • The MRQ is 2.480. The company is able to pay all its short-term debts. +1
  • The TTM is 2.703. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.480TTM2.703-0.223
TTM2.703YOY3.225-0.522
TTM2.7035Y4.430-1.727
5Y4.43010Y3.435+0.995
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4802.111+0.369
TTM2.7032.085+0.618
YOY3.2252.554+0.671
3Y3.3832.512+0.871
5Y4.4302.689+1.741
10Y3.4352.603+0.832
4.4.3.2. Quick Ratio

Measures if Milestone Scientific is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Milestone Scientific to theΒ Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 1.00Β means the company can pay off $1.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Milestone Scientific:

  • The MRQ is 0.997. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.036. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ0.997TTM1.036-0.039
TTM1.036YOY2.473-1.437
TTM1.0365Y4.882-3.846
5Y4.88210Y3.135+1.747
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9970.949+0.048
TTM1.0361.061-0.025
YOY2.4731.172+1.301
3Y3.0221.310+1.712
5Y4.8821.498+3.384
10Y3.1351.668+1.467
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Milestone Scientific.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Milestone ScientificΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Milestone Scientific to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.40Β means that Milestone Scientific assets areΒ financed with 40.5% credit (debt) and the remaining percentage (100% - 40.5%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Milestone Scientific:

  • The MRQ is 0.405. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.375. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.405TTM0.375+0.030
TTM0.375YOY0.322+0.053
TTM0.3755Y0.266+0.110
5Y0.26610Y0.403-0.137
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4050.389+0.016
TTM0.3750.371+0.004
YOY0.3220.345-0.023
3Y0.3170.347-0.030
5Y0.2660.358-0.092
10Y0.4030.375+0.028
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Milestone Scientific is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Milestone Scientific to theΒ Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 68.0% means that company has $0.68 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Milestone Scientific:

  • The MRQ is 0.680. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.604. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.680TTM0.604+0.076
TTM0.604YOY0.468+0.136
TTM0.6045Y0.374+0.230
5Y0.37410Y1.215-0.841
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6800.598+0.082
TTM0.6040.597+0.007
YOY0.4680.538-0.070
3Y0.4690.550-0.081
5Y0.3740.571-0.197
10Y1.2150.666+0.549
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Milestone Scientific generates.

  • Above 15 is considered overpriced butΒ always compareΒ Milestone Scientific to theΒ Medical Instruments & Supplies industry mean.
  • A PE ratio of -9.14 means the investor is paying $-9.14Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Milestone Scientific:

  • The EOD is -9.310. Based on the earnings, the company is expensive. -2
  • The MRQ is -9.139. Based on the earnings, the company is expensive. -2
  • The TTM is 7.561. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-9.310MRQ-9.139-0.171
MRQ-9.139TTM7.561-16.700
TTM7.561YOY-8.896+16.457
TTM7.5615Y-13.270+20.831
5Y-13.27010Y-15.423+2.153
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-9.31013.961-23.271
MRQ-9.13915.324-24.463
TTM7.56115.666-8.105
YOY-8.89619.364-28.260
3Y-3.10019.721-22.821
5Y-13.27022.342-35.612
10Y-15.42322.404-37.827
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Milestone Scientific:

  • The EOD is -12.508. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -12.279. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.483. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.508MRQ-12.279-0.229
MRQ-12.279TTM-6.483-5.796
TTM-6.483YOY-13.699+7.216
TTM-6.4835Y-23.606+17.122
5Y-23.60610Y-24.747+1.142
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-12.50811.181-23.689
MRQ-12.27912.106-24.385
TTM-6.4839.530-16.013
YOY-13.6995.178-18.877
3Y-9.955-0.600-9.355
5Y-23.6062.348-25.954
10Y-24.747-2.194-22.553
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Milestone Scientific is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 12.76 means the investor is paying $12.76Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Milestone Scientific:

  • The EOD is 12.996. Based on the equity, the company is expensive. -2
  • The MRQ is 12.758. Based on the equity, the company is expensive. -2
  • The TTM is 10.653. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD12.996MRQ12.758+0.238
MRQ12.758TTM10.653+2.105
TTM10.653YOY8.145+2.508
TTM10.6535Y8.839+1.814
5Y8.83910Y18.052-9.214
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD12.9962.371+10.625
MRQ12.7582.507+10.251
TTM10.6532.828+7.825
YOY8.1452.844+5.301
3Y8.1483.058+5.090
5Y8.8393.680+5.159
10Y18.0524.263+13.789
4.6.2. Total Gains per Share

2.4. Latest News of Milestone Scientific

Does Milestone Scientific still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Milestone Scientific to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-04-15
22:10
Milestone Scientific Reports Year-End 2024 Financial ResultsΒ and Reports Strong Outlook for 2025Read

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Milestone Scientific.

4.8.3. Insider Transactions

Insiders are holding 22.756% of the shares of Milestone Scientific.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-06-16Goldman Neal IBUY97200.751195934
2022-06-15Goldman Neal IBUY52700.81186214
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets9,797
Total Liabilities3,964
Total Stockholder Equity5,833
 As reported
Total Liabilities 3,964
Total Stockholder Equity+ 5,833
Total Assets = 9,797

Assets

Total Assets9,797
Total Current Assets9,287
Long-term Assets511
Total Current Assets
Cash And Cash Equivalents 3,258
Net Receivables 475
Inventory 3,713
Other Current Assets 1,840
Total Current Assets  (as reported)9,287
Total Current Assets  (calculated)9,287
+/-0
Long-term Assets
Property Plant Equipment 338
Intangible Assets 148
Long-term Assets Other 24
Long-term Assets  (as reported)511
Long-term Assets  (calculated)511
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,744
Long-term Liabilities220
Total Stockholder Equity5,833
Total Current Liabilities
Short-term Debt 129
Accounts payable 1,021
Other Current Liabilities 2,594
Total Current Liabilities  (as reported)3,744
Total Current Liabilities  (calculated)3,744
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)220
Long-term Liabilities  (calculated)0
+/- 220
Total Stockholder Equity
Common Stock78
Retained Earnings -128,053
Other Stockholders Equity 133,808
Total Stockholder Equity (as reported)5,833
Total Stockholder Equity (calculated)5,833
+/-0
Other
Cash and Short Term Investments 3,258
Common Stock Shares Outstanding 79,791
Liabilities and Stockholders Equity 9,797
Net Debt -2,909
Net Working Capital 5,542
Short Long Term Debt Total 349



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-30
> Total Assets 
4,100
3,900
4,700
6,900
6,100
16,500
20,000
22,600
19,700
15,400
9,200
10,200
8,200
6,900
5,622
5,556
4,911
5,314
2,554
2,991
2,039
1,703
1,516
1,446
1,713
1,675
1,241
1,449
1,359
1,514
1,716
7,924
7,094
5,975
5,369
7,648
7,753
7,353
7,050
6,779
6,129
5,348
5,142
5,417
4,725
4,355
4,990
4,284
3,989
3,803
4,411
4,163
3,715
3,900
4,850
5,908
6,632
7,090
6,609
6,976
7,382
7,046
6,992
6,477
6,261
5,932
5,661
5,830
5,638
6,348
8,055
8,091
17,262
17,270
17,477
16,654
15,340
14,065
12,809
11,607
12,602
11,618
13,551
12,149
13,097
15,542
15,629
14,352
13,429
7,625
6,401
7,962
6,788
6,243
6,556
6,375
20,964
19,946
19,571
22,641
21,060
20,077
19,810
19,065
16,512
15,278
13,702
12,273
11,151
10,584
11,372
11,351
12,005
11,175
9,797
9,797
9,7979,79711,17512,00511,35111,37210,58411,15112,27313,70215,27816,51219,06519,81020,07721,06022,64119,57119,94620,9646,3756,5566,2436,7887,9626,4017,62513,42914,35215,62915,54213,09712,14913,55111,61812,60211,60712,80914,06515,34016,65417,47717,27017,2628,0918,0556,3485,6385,8305,6615,9326,2616,4776,9927,0467,3826,9766,6097,0906,6325,9084,8503,9003,7154,1634,4113,8033,9894,2844,9904,3554,7255,4175,1425,3486,1296,7797,0507,3537,7537,6485,3695,9757,0947,9241,7161,5141,3591,4491,2411,6751,7131,4461,5161,7032,0392,9912,5545,3144,9115,5565,6226,9008,20010,2009,20015,40019,70022,60020,00016,5006,1006,9004,7003,9004,100
   > Total Current Assets 
1,800
1,600
1,600
4,500
3,600
13,800
17,200
18,300
13,400
9,500
5,400
6,500
4,700
3,600
2,450
2,558
2,088
2,648
1,966
2,653
1,785
1,467
888
827
834
904
893
1,141
1,112
1,275
1,198
7,572
6,516
5,385
4,565
6,657
6,757
6,271
5,926
5,687
5,041
4,284
4,065
4,357
3,688
3,419
4,106
3,333
2,992
2,766
2,858
2,601
2,159
2,285
3,304
4,344
5,162
5,668
3,388
3,358
3,391
3,113
3,298
3,009
2,956
2,830
2,499
2,662
2,760
3,598
4,880
6,371
15,644
15,611
15,582
15,068
14,409
13,271
11,824
10,656
11,694
10,741
12,714
11,337
11,499
11,593
12,020
11,007
10,977
7,055
5,856
7,314
6,296
5,756
6,093
5,261
19,881
18,892
18,555
21,659
20,105
19,159
18,934
18,228
15,714
14,515
12,971
11,581
10,500
9,973
10,794
10,812
11,494
10,699
9,287
9,287
9,2879,28710,69911,49410,81210,7949,97310,50011,58112,97114,51515,71418,22818,93419,15920,10521,65918,55518,89219,8815,2616,0935,7566,2967,3145,8567,05510,97711,00712,02011,59311,49911,33712,71410,74111,69410,65611,82413,27114,40915,06815,58215,61115,6446,3714,8803,5982,7602,6622,4992,8302,9563,0093,2983,1133,3913,3583,3885,6685,1624,3443,3042,2852,1592,6012,8582,7662,9923,3334,1063,4193,6884,3574,0654,2845,0415,6875,9266,2716,7576,6574,5655,3856,5167,5721,1981,2751,1121,1418939048348278881,4671,7852,6531,9662,6482,0882,5582,4503,6004,7006,5005,4009,50013,40018,30017,20013,8003,6004,5001,6001,6001,800
       Cash And Cash Equivalents 
1,700
1,400
800
3,400
2,400
12,700
9,800
5,600
3,000
2,200
300
2,400
800
900
243
458
49
561
173
568
25
23
16
29
23
13
10
1
28
96
3
6,333
5,235
4,022
3,041
3,896
4,513
3,652
2,893
2,445
1,999
1,425
1,160
451
193
45
745
238
261
286
744
501
499
497
1,029
1,218
820
208
627
155
99
371
96
113
122
274
165
122
172
402
1,147
1,399
1,122
781
10,368
9,331
1,447
4,391
4,194
2,672
3,184
2,323
3,602
2,942
2,946
2,307
2,637
2,094
866
415
743
2,740
2,338
1,711
1,516
766
16,610
14,449
14,224
16,951
15,977
14,491
14,764
13,255
10,959
9,812
8,715
2,278
3,701
2,171
2,978
4,005
5,752
4,776
3,258
3,258
3,2583,2584,7765,7524,0052,9782,1713,7012,2788,7159,81210,95913,25514,76414,49115,97716,95114,22414,44916,6107661,5161,7112,3382,7407434158662,0942,6372,3072,9462,9423,6022,3233,1842,6724,1944,3911,4479,33110,3687811,1221,3991,14740217212216527412211396371991556272088201,2181,029497499501744286261238745451934511,1601,4251,9992,4452,8933,6524,5133,8963,0414,0225,2356,33339628110132329162325568173561494582439008002,4003002,2003,0005,6009,80012,7002,4003,4008001,4001,700
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
1,700
500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,133
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,498
9,500
0
0
5,550
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,000
14,800
14,300
13,900
12,400
10,700
9,700
8,300
4,430
1,981
2,450
2,977
1,000
0
0
0
0
00001,0002,9772,4501,9814,4308,3009,70010,70012,40013,90014,30014,80015,00000000000000000000000005,550009,5009,4980000000000000000000000000000000000001,1330000000000000000000005001,700000000000000
       Net Receivables 
0
0
300
500
600
400
300
3,800
1,500
500
400
500
300
200
298
471
592
721
530
702
400
187
679
625
654
768
539
914
893
862
389
483
509
483
421
523
777
886
533
635
554
315
407
1,462
735
624
362
359
573
749
926
1,099
798
613
1,064
931
1,804
2,122
796
1,380
1,686
1,043
1,154
1,069
1,082
794
979
1,320
1,061
1,570
1,533
1,221
1,443
1,624
1,541
2,028
1,635
2,349
1,852
2,269
2,583
2,553
3,517
2,309
2,276
3,212
3,761
3,059
4,658
2,273
2,078
1,563
1,659
1,239
1,711
1,290
107
963
1,081
1,246
812
968
943
1,334
1,095
1,092
694
912
790
591
313
662
387
551
475
475
4754755513876623135917909126941,0921,0951,3349439688121,2461,0819631071,2901,7111,2391,6591,5632,0782,2734,6583,0593,7613,2122,2762,3093,5172,5532,5832,2691,8522,3491,6352,0281,5411,6241,4431,2211,5331,5701,0611,3209797941,0821,0691,1541,0431,6861,3807962,1221,8049311,0646137981,0999267495733593626247351,4624073155546355338867775234214835094833898628939145397686546256791874007025307215924712982003005004005001,5003,80030040060050030000
       Inventory 
100
100
500
500
600
600
1,200
800
2,600
2,800
1,300
1,600
1,600
1,900
1,717
1,468
1,386
1,133
1,039
1,265
1,280
1,176
163
123
116
82
119
107
157
255
427
431
536
769
936
936
1,050
1,310
1,371
1,346
1,286
1,456
1,323
1,224
1,566
1,657
1,637
1,339
1,088
845
720
648
633
889
805
965
1,265
1,153
987
851
598
734
790
589
514
671
639
626
857
875
1,322
1,745
1,964
2,241
2,497
2,766
3,240
2,805
4,258
3,898
4,269
4,319
4,603
4,534
4,498
4,166
3,379
3,265
2,310
2,246
1,921
1,861
1,270
1,617
1,621
1,723
1,852
2,230
2,420
2,021
1,479
1,677
1,542
1,800
1,505
1,552
1,792
2,038
2,193
2,483
2,638
2,860
3,329
3,712
3,713
3,713
3,7133,7133,7123,3292,8602,6382,4832,1932,0381,7921,5521,5051,8001,5421,6771,4792,0212,4202,2301,8521,7231,6211,6171,2701,8611,9212,2462,3103,2653,3794,1664,4984,5344,6034,3194,2693,8984,2582,8053,2402,7662,4972,2411,9641,7451,3228758576266396715145897907345988519871,1531,2659658058896336487208451,0881,3391,6371,6571,5661,2241,3231,4561,2861,3461,3711,3101,050936936769536431427255157107119821161231631,1761,2801,2651,0391,1331,3861,4681,7171,9001,6001,6001,3002,8002,6008001,200600600500500100100
   > Long-term Assets 
2,300
2,300
3,100
2,400
2,500
2,700
0
4,300
6,300
5,900
3,800
3,700
3,500
3,300
3,172
2,998
2,824
2,667
0
338
254
236
628
620
879
771
347
307
248
239
518
352
577
591
804
991
996
1,082
1,123
1,092
1,089
1,064
0
1,060
1,037
937
884
951
996
1,037
1,553
1,562
1,556
1,616
1,546
1,564
1,470
1,422
3,221
3,618
3,991
3,934
3,694
3,468
3,305
3,102
3,162
3,168
2,878
2,750
3,176
1,719
1,618
1,659
1,895
1,585
931
793
985
951
909
877
837
812
1,598
3,949
142
3,345
2,453
570
545
647
492
487
463
1,113
1,083
1,054
1,017
982
954
918
876
838
799
764
732
692
651
611
577
539
512
476
511
511
5115114765125395776116516927327647998388769189549821,0171,0541,0831,1134634874926475455702,4533,3451423,9491,5988128378779099519857939311,5851,8951,6591,6181,7193,1762,7502,8783,1683,1623,1023,3053,4683,6943,9343,9913,6183,2211,4221,4701,5641,5461,6161,5561,5621,5531,0379969518849371,0371,06001,0641,0891,0921,1231,08299699180459157735251823924830734777187962062823625433802,6672,8242,9983,1723,3003,5003,7003,8005,9006,3004,30002,7002,5002,4003,1002,3002,300
       Property Plant Equipment 
200
200
300
300
500
700
800
2,400
4,500
4,100
2,000
2,000
1,900
1,700
1,670
1,557
1,444
1,348
273
251
241
224
208
197
201
236
227
213
213
205
242
326
550
569
612
589
582
559
536
510
496
473
459
450
433
235
221
205
175
162
153
167
155
150
77
79
63
67
67
64
62
57
52
47
45
40
37
33
31
27
24
25
38
78
89
85
117
116
236
221
202
182
159
142
171
120
142
116
106
95
83
208
66
55
45
720
703
687
663
640
624
599
574
549
524
502
479
453
426
398
374
346
325
286
338
338
3383382863253463743984264534795025245495745996246406636877037204555662088395106116142120171142159182202221236116117858978382524273133374045475257626467676379771501551671531621752052212354334504594734965105365595825896125695503262422052132132272362011972082242412512731,3481,4441,5571,6701,7001,9002,0002,0004,1004,5002,400800700500300300200200
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
333
519
462
353
283
241
119
131
50
50
966
891
795
816
1,262
972
301
180
16
0
0
0
0
0
0
0
0
650
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000065000000000161803019721,2628167958919665050131119241283353462519333000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
2,200
2,100
2,000
2,000
2,000
2,000
2,000
1,900
1,900
1,800
1,700
1,700
1,600
1,600
1,492
1,431
1,369
1,308
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
101
314
327
420
487
484
497
498
527
521
515
599
559
645
735
789
901
895
909
922
947
967
963
952
945
936
924
713
698
690
673
663
649
638
626
608
592
572
553
533
530
513
495
480
716
712
695
678
660
643
625
3,152
2,790
2,552
2,320
449
435
422
409
396
382
369
356
343
329
318
307
295
278
264
251
238
228
215
202
188
179
169
162
155
148
148
1481481551621691791882022152282382512642782953073183293433563693823964094224354492,3202,5522,7903,15262564366067869571271648049551353053355357259260862663864966367369069871392493694595296396794792290989590178973564555959951552152749849748448742032731410100000000000000001,3081,3691,4311,4921,6001,6001,7001,7001,8001,9001,9002,0002,0002,0002,0002,0002,1002,200
       Long-term Assets Other 
-100
0
800
100
0
0
0
0
-100
0
100
100
0
0
10
10
10
10
315
87
12
12
420
423
678
535
120
94
35
34
276
26
27
22
90
89
87
103
101
98
95
93
90
90
89
104
104
101
86
86
7
7
16
144
134
116
100
74
58
41
24
38
28
20
10
7
2,477
7
7
13
13
13
13
13
15
15
17
17
17
17
11
17
17
27
802
677
27
677
27
27
27
17
17
36
36
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
35
24
24
2424352424242424242424242424242424242424243636171727272767727677802271717111717171715151313131313772,477710202838244158741001161341441677868610110410489909093959810110387899022272627634359412053567842342012128731510101010001001000-10000001008000-100
> Total Liabilities 
-100
200
700
700
1,100
1,000
1,500
2,600
3,500
1,800
900
1,200
3,000
3,200
3,493
2,186
2,627
3,783
4,256
5,239
5,389
5,736
5,975
5,907
6,658
6,963
7,347
8,063
8,609
4,391
4,161
879
1,072
967
849
1,036
1,022
1,069
731
1,056
1,318
1,026
1,428
1,956
2,167
2,727
3,451
2,723
2,732
2,658
3,011
3,104
3,171
3,130
2,209
2,985
3,423
4,279
4,277
4,688
5,272
4,911
5,056
4,622
4,369
3,970
3,725
3,412
2,976
2,554
2,536
2,208
1,948
2,001
2,435
1,857
1,940
2,132
3,644
3,242
3,991
4,397
5,014
3,622
5,436
6,454
8,128
8,401
8,110
6,579
4,873
5,235
5,951
7,647
4,928
5,887
3,995
4,101
3,464
3,604
3,491
4,049
3,594
4,299
3,837
4,098
3,696
3,021
3,450
3,591
3,359
3,890
4,051
3,953
3,964
3,964
3,9643,9643,9534,0513,8903,3593,5913,4503,0213,6964,0983,8374,2993,5944,0493,4913,6043,4644,1013,9955,8874,9287,6475,9515,2354,8736,5798,1108,4018,1286,4545,4363,6225,0144,3973,9913,2423,6442,1321,9401,8572,4352,0011,9482,2082,5362,5542,9763,4123,7253,9704,3694,6225,0564,9115,2724,6884,2774,2793,4232,9852,2093,1303,1713,1043,0112,6582,7322,7233,4512,7272,1671,9561,4281,0261,3181,0567311,0691,0221,0368499671,0728794,1614,3918,6098,0637,3476,9636,6585,9075,9755,7365,3895,2394,2563,7832,6272,1863,4933,2003,0001,2009001,8003,5002,6001,5001,0001,100700700200-100
   > Total Current Liabilities 
100
100
700
700
1,100
1,000
1,500
2,600
3,500
1,800
900
1,200
700
900
1,243
1,186
2,627
2,459
1,855
3,198
3,203
3,719
1,169
1,779
1,268
5,440
6,107
6,684
7,255
2,723
4,120
879
1,072
967
699
848
797
807
731
1,056
1,318
1,026
1,428
1,956
2,167
2,351
2,073
1,782
1,505
1,423
1,325
1,410
2,734
2,692
1,678
2,407
2,850
3,710
3,395
3,536
3,960
3,588
4,609
4,173
3,919
3,520
3,275
2,962
2,526
2,554
2,536
2,208
1,948
2,001
2,435
1,857
1,940
2,132
3,644
3,242
3,991
4,397
5,014
3,622
4,036
5,054
6,728
7,001
8,110
6,579
4,873
5,219
5,951
7,647
4,928
5,240
3,368
3,494
2,878
3,039
2,949
3,529
3,097
3,827
3,389
3,675
3,300
2,653
3,109
3,279
3,077
3,637
3,826
3,758
3,744
3,744
3,7443,7443,7583,8263,6373,0773,2793,1092,6533,3003,6753,3893,8273,0973,5292,9493,0392,8783,4943,3685,2404,9287,6475,9515,2194,8736,5798,1107,0016,7285,0544,0363,6225,0144,3973,9913,2423,6442,1321,9401,8572,4352,0011,9482,2082,5362,5542,5262,9623,2753,5203,9194,1734,6093,5883,9603,5363,3953,7102,8502,4071,6782,6922,7341,4101,3251,4231,5051,7822,0732,3512,1671,9561,4281,0261,3181,0567318077978486999671,0728794,1202,7237,2556,6846,1075,4401,2681,7791,1693,7193,2033,1981,8552,4592,6271,1861,2439007001,2009001,8003,5002,6001,5001,0001,100700700100100
       Short-term Debt 
0
0
100
100
300
200
200
200
2,900
200
200
200
100
0
0
0
956
1,040
200
917
927
1,351
0
200
0
3,600
4,582
4,879
5,303
1,292
1,499
87
46
48
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200
0
0
1,264
1,271
0
0
0
0
0
0
0
0
0
0
0
0
0
381
405
45
50
0
0
0
50
50
0
0
0
0
0
0
0
1,082
381
902
0
986
1,353
1,453
0
114
186
110
32
144
345
353
356
358
168
174
179
185
190
196
202
208
214
110
227
116
231
116
0
129
12901162311162271102142082021961901851791741683583563533451443211018611401,4531,35398609023811,08200000005050000504540538100000000000001,2711,264002000000000000000004846871,4991,2925,3034,8794,5823,600020001,3519279172001,0409560001002002002002,90020020020030010010000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
114
0
0
0
0
272
276
276
276
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000276276276272000011400000000000000005000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
100
500
500
700
800
0
1,800
100
1,200
500
900
400
700
996
1,039
1,459
1,024
1,149
1,666
1,525
1,454
1,063
1,299
1,170
1,342
1,270
1,452
1,540
1,177
1,690
662
633
492
474
496
357
551
508
631
1,032
695
1,197
1,462
1,858
2,123
1,856
1,466
1,221
828
829
1,078
1,009
881
1,154
1,952
2,253
3,054
2,884
2,886
2,890
2,704
3,932
3,407
3,086
2,605
2,337
2,030
1,506
1,806
2,020
1,217
984
1,341
2,435
1,230
796
781
3,644
1,866
2,498
2,274
2,576
889
986
616
4,251
1,557
1,365
1,307
4,351
1,199
1,193
740
1,379
1,444
462
666
483
694
583
744
780
1,012
1,385
1,283
1,103
824
675
1,786
1,100
1,895
2,218
1,138
1,021
1,021
1,0211,0211,1382,2181,8951,1001,7866758241,1031,2831,3851,0127807445836944836664621,4441,3797401,1931,1994,3511,3071,3651,5574,2516169868892,5762,2742,4981,8663,6447817961,2302,4351,3419841,2172,0201,8061,5062,0302,3372,6053,0863,4073,9322,7042,8902,8862,8843,0542,2531,9521,1548811,0091,0788298281,2211,4661,8562,1231,8581,4621,1976951,0326315085513574964744926336621,6901,1771,5401,4521,2701,3421,1701,2991,0631,4541,5251,6661,1491,0241,4591,0399967004009005001,2001001,80008007005005001000
       Other Current Liabilities 
100
0
100
100
100
0
0
600
500
400
200
100
200
200
246
146
212
395
506
615
751
914
106
280
97
497
256
353
411
255
931
130
393
426
225
353
440
256
223
425
286
331
232
494
309
228
217
316
284
395
496
332
461
540
524
455
598
656
511
650
1,070
884
677
766
834
915
938
932
1,020
702
515
484
755
610
981
627
1,144
1,351
1,556
1,375
1,493
2,123
1,436
2,377
2,034
3,065
3,877
3,004
3,290
3,521
522
3,425
4,200
6,425
3,176
3,241
2,221
2,134
2,933
1,746
1,860
2,205
2,138
2,630
1,813
2,197
1,995
1,621
2,220
1,383
1,749
1,626
1,378
2,504
0
2,594
2,59402,5041,3781,6261,7491,3832,2201,6211,9952,1971,8132,6302,1382,2051,8601,7462,9332,1342,2213,2413,1766,4254,2003,4255223,5213,2903,0043,8773,0652,0342,3771,4362,1231,4931,3751,5561,3511,1446279816107554845157021,0209329389158347666778841,07065051165659845552454046133249639528431621722830949423233128642522325644035322542639313093125541135325649797280106914751615506395212146246200200100200400500600001001001000100
   > Long-term Liabilities 
-200
100
0
0
0
0
0
0
0
0
0
2,250
2,300
2,300
2,250
1,000
0
1,324
0
2,041
2,187
2,016
4,806
4,129
5,390
1,524
1,239
1,379
1,355
1,668
41
41
0
0
150
188
225
263
0
0
0
0
0
0
0
376
1,378
941
1,227
1,235
1,686
1,693
437
438
531
578
573
569
882
1,153
1,313
1,323
447
448
450
450
450
450
450
0
0
0
0
0
0
486
841
835
0
0
182
269
0
0
1,400
1,400
0
1,400
0
0
0
16
0
0
0
647
627
607
587
565
543
520
497
473
448
422
396
369
340
312
282
254
225
196
220
220
220220196225254282312340369396422448473497520543565587607627647000160001,40001,4001,40000269182008358414860000004504504504504504484471,3231,3131,1538825695735785314384371,6931,6861,2351,2279411,37837600000002632251881500041411,6681,3551,3791,2391,5245,3904,1294,8062,0162,1872,04101,32401,0002,2502,3002,3002,250000000000100-200
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
444
445
447
448
450
450
450
450
450
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000003500000000000000000000000000450450450450450448447445444000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,052
298
772
358
460
562
597
1,053
0
0
0
0
149
188
225
263
0
0
0
0
0
0
0
0
444
0
0
0
0
0
0
0
0
138
133
127
440
710
868
877
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,400
1,400
1,400
1,400
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000001,4001,4001,4001,4000000000000000000000000877868710440127133138000000004440000000026322518814900001,0535975624603587722981,0520000000000000000000000
> Total Stockholder Equity
4,100
3,700
4,000
6,200
5,000
15,500
0
20,000
16,200
13,600
8,300
9,000
5,200
3,700
2,130
3,371
2,285
1,531
0
-2,248
-3,351
-4,033
0
-4,461
-4,945
-5,288
-6,106
-6,614
-7,250
-2,877
-2,445
7,045
6,021
5,008
4,521
6,612
6,731
6,283
6,318
5,724
4,812
4,322
3,713
3,462
2,558
1,629
1,538
1,561
1,257
1,145
1,400
1,060
544
771
2,641
2,923
3,208
2,812
2,332
2,288
2,110
2,135
1,936
1,856
1,891
1,961
1,937
2,418
2,662
3,794
5,520
5,882
15,314
15,269
14,648
14,311
12,560
11,098
10,309
10,003
8,430
6,952
8,500
8,564
7,356
8,787
7,244
5,796
5,171
916
1,540
2,748
871
-1,358
1,696
568
17,036
15,923
16,201
19,145
17,692
16,164
16,368
14,936
12,869
11,387
10,226
9,483
7,945
7,246
8,013
7,460
7,954
7,221
5,833
5,833
5,8335,8337,2217,9547,4608,0137,2467,9459,48310,22611,38712,86914,93616,36816,16417,69219,14516,20115,92317,0365681,696-1,3588712,7481,5409165,1715,7967,2448,7877,3568,5648,5006,9528,43010,00310,30911,09812,56014,31114,64815,26915,3145,8825,5203,7942,6622,4181,9371,9611,8911,8561,9362,1352,1102,2882,3322,8123,2082,9232,6417715441,0601,4001,1451,2571,5611,5381,6292,5583,4623,7134,3224,8125,7246,3186,2836,7316,6124,5215,0086,0217,045-2,445-2,877-7,250-6,614-6,106-5,288-4,945-4,4610-4,033-3,351-2,24801,5312,2853,3712,1303,7005,2009,0008,30013,60016,20020,000015,5005,0006,2004,0003,7004,100
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
-2,200
0
0
9
11
11
11
11
11
11
11
11
12
12
13
13
13
13
18
6
10
10
10
10
11
11
11
12
12
12
12
12
12
12
12
12
13
13
13
13
14
14
14
15
16
16
16
16
16
16
17
17
17
18
18
18
18
19
19
20
20
22
22
22
22
22
22
23
23
28
29
32
32
33
34
35
35
36
36
36
44
47
48
49
50
63
64
64
67
67
68
68
68
69
69
69
70
70
71
76
77
77
78
0
78
78078777776717070696969686868676764646350494847443636363535343332322928232322222222222220201919181818181717171616161616161514141413131313121212121212121212111111101010106181313131312121111111111111111900-2,20000000000000
   Retained Earnings -128,053-128,053-126,018-124,556-124,780-123,340-121,401-119,934-117,718-116,410-114,436-112,464-109,606-107,704-106,583-104,539-101,859-100,886-99,806-98,315-95,125-93,524-90,661-87,824-86,783-86,000-86,180-81,785-80,442-78,568-76,779-75,365-73,886-73,381-71,643-69,814-68,185-67,435-66,029-64,460-62,387-61,967-60,599-60,240-60,071-60,265-61,287-61,506-61,580-61,730-61,365-61,380-61,215-60,860-60,455-59,818-59,520-59,378-59,083-58,499-58,680-58,763-58,825-58,452-57,795-57,233-57,322-57,135-56,662-56,046-55,693-54,711-53,642-53,107-52,216-51,595-50,641-49,955-49,478-48,865-48,075-47,197-46,629-45,546-44,718-44,200-43,574-42,946-42,295-41,787-40,951-40,369-39,867-39,347-38,610-37,800-36,690-35,355-31,146-30,121-29,058-27,845-25,500-24,000-22,400-20,900-15,600-13,000-9,800-10,200-5,900-4,600-3,400-2,700-2,200-1,400
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
62,823
63,485
63,691
63,965
64,165
64,220
64,560
64,891
65,061
65,973
66,677
66,845
76,444
76,757
77,504
77,587
77,909
78,016
78,632
79,077
79,127
79,477
82,762
83,330
83,600
86,443
86,689
87,115
87,832
87,971
88,415
90,399
89,560
90,166
96,082
96,554
116,200
116,577
117,935
121,848
123,076
123,590
0
0
0
0
0
128,043
128,721
0
0
0
0
0
0
0
0000000128,721128,04300000123,590123,076121,848117,935116,577116,20096,55496,08290,16689,56090,39988,41587,97187,83287,11586,68986,44383,60083,33082,76279,47779,12779,07778,63278,01677,90977,58777,50476,75776,44466,84566,67765,97365,06164,89164,56064,22064,16563,96563,69163,48562,823000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000-912-91200000-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-912-911-911-912-911-912-912-911-911000000000000000
   Other Stockholders Equity 
5,500
5,900
6,700
9,600
9,600
21,400
0
29,900
29,300
29,300
29,300
29,300
29,200
29,200
29,966
32,417
32,395
32,667
0
34,786
34,786
34,884
0
35,696
35,696
35,966
36,056
35,688
35,703
40,699
41,906
51,754
51,662
51,628
51,915
54,677
55,585
55,750
56,568
56,352
56,394
56,526
0
57,092
57,257
57,309
57,572
58,211
58,379
58,454
58,620
58,841
58,982
59,581
61,389
61,587
61,692
61,879
61,695
61,792
61,912
62,574
62,779
63,054
63,253
63,308
63,649
64,442
64,617
65,062
65,766
65,933
75,532
75,846
0
76,675
76,997
77,105
0
78,165
78,215
78,566
81,850
82,418
82,689
85,531
0
86,204
86,921
87,060
0
89,487
88,648
89,255
95,171
95,642
115,288
115,666
117,023
120,937
122,164
122,679
124,004
124,474
125,264
125,755
126,567
127,131
127,809
128,576
131,276
132,164
132,433
133,161
0
133,808
133,8080133,161132,433132,164131,276128,576127,809127,131126,567125,755125,264124,474124,004122,679122,164120,937117,023115,666115,28895,64295,17189,25588,64889,487087,06086,92186,204085,53182,68982,41881,85078,56678,21578,165077,10576,99776,675075,84675,53265,93365,76665,06264,61764,44263,64963,30863,25363,05462,77962,57461,91261,79261,69561,87961,69261,58761,38959,58158,98258,84158,62058,45458,37958,21157,57257,30957,25757,092056,52656,39456,35256,56855,75055,58554,67751,91551,62851,66251,75441,90640,69935,70335,68836,05635,96635,69635,696034,88434,78634,786032,66732,39532,41729,96629,20029,20029,30029,30029,30029,30029,900021,4009,6009,6006,7005,9005,500



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue6,435
Cost of Revenue-2,195
Gross Profit6,4354,239
 
Operating Income (+$)
Gross Profit6,435
Operating Expense-13,192
Operating Income-6,757-6,757
 
Operating Expense (+$)
Research Development859
Selling General Administrative12,295
Selling And Marketing Expenses0
Operating Expense13,19213,154
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-60
Net Interest Income60
 
Pretax Income (+$)
Operating Income-6,757
Net Interest Income60
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-4,714-8,800
EBIT - interestExpense = -6,757
-4,714
-4,714
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-6,757-4,714
Earnings Before Interest and Taxes (EBITDA)-6,720
 
After tax Income (+$)
Income Before Tax-4,714
Tax Provision-0
Net Income From Continuing Ops-4,714-4,714
Net Income-4,714
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses13,192
Total Other Income/Expenses Net2,043-60
 

Technical Analysis of Milestone Scientific
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Milestone Scientific. The general trend of Milestone Scientific is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Milestone Scientific's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Milestone Scientific Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Milestone Scientific.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.1 < 1.11 < 1.12.

The bearish price targets are: 0.89 > 0.85 > 0.82.

Know someone who trades $MLSS? Share this with them.πŸ‘‡

Milestone Scientific Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Milestone Scientific. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Milestone Scientific Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Milestone Scientific. The current macd is 0.00233892.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Milestone Scientific price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Milestone Scientific. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Milestone Scientific price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Milestone Scientific Daily Moving Average Convergence/Divergence (MACD) ChartMilestone Scientific Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Milestone Scientific. The current adx is 12.08.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Milestone Scientific shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Milestone Scientific Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Milestone Scientific. The current sar is 1.10208.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Milestone Scientific Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Milestone Scientific. The current rsi is 48.78. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Milestone Scientific Daily Relative Strength Index (RSI) ChartMilestone Scientific Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Milestone Scientific. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Milestone Scientific price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Milestone Scientific Daily Stochastic Oscillator ChartMilestone Scientific Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Milestone Scientific. The current cci is 16.37.

Milestone Scientific Daily Commodity Channel Index (CCI) ChartMilestone Scientific Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Milestone Scientific. The current cmo is -3.71915428.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Milestone Scientific Daily Chande Momentum Oscillator (CMO) ChartMilestone Scientific Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Milestone Scientific. The current willr is -69.50477845.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Milestone Scientific is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Milestone Scientific Daily Williams %R ChartMilestone Scientific Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Milestone Scientific.

Milestone Scientific Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Milestone Scientific. The current atr is 0.07954034.

Milestone Scientific Daily Average True Range (ATR) ChartMilestone Scientific Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Milestone Scientific. The current obv is 9,741,277.

Milestone Scientific Daily On-Balance Volume (OBV) ChartMilestone Scientific Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Milestone Scientific. The current mfi is 74.73.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Milestone Scientific Daily Money Flow Index (MFI) ChartMilestone Scientific Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Milestone Scientific.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-12-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-31BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-13ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-04-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-02MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Milestone Scientific Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Milestone Scientific based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.780
Ma 20Greater thanMa 500.953
Ma 50Greater thanMa 1000.963
Ma 100Greater thanMa 2001.026
OpenGreater thanClose0.980
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Milestone Scientific with someone you think should read this too:
  • Are you bullish or bearish on Milestone Scientific? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Milestone Scientific? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Milestone Scientific

I send you an email if I find something interesting about Milestone Scientific.


Comments

How you think about this?

Leave a comment

Stay informed about Milestone Scientific.

Receive notifications about Milestone Scientific in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.